Highlights

• Arvee Laboratories (India) Limited shares fell 6.81% to ₹163.82 on April 13, 2026.
• The stock opened at ₹176.66 but could not hold higher levels and ended sharply lower.
• Despite the decline, the stock remains above its 50-day SMA near ₹154.54.

Overview

Arvee Laboratories (India) Limited (NSE: ARVEE) declined 6.81% to ₹163.82 on April 13, 2026. The stock opened at ₹176.66, which also remained the session high, before slipping steadily through the day. It touched an intraday low of ₹158.22 and closed well below the opening level.

The latest move came after a strong rebound from March lows near ₹135.00. The stock had recently climbed back above its 50-day Simple Moving Average and moved toward the upper end of its recent trading range. However, the inability to sustain near ₹178.00 suggests that near-term profit booking has emerged.

Fundamental View

For the quarter ended December 2025, Arvee Laboratories reported standalone total income of ₹991.60 lakh.

Profit before tax stood at ₹139.22 lakh, while net profit came in at ₹182.69 lakh. Earnings per share was reported at ₹1.66.

The company remains profitable, which is a more supportive backdrop than several other small-cap names. However, the current correction suggests that traders may be focusing more on short-term price action after the recent rally.

Technical View

The latest session reflects a sharp reversal after the recent rebound lost pace near the upper end of the range. Arvee Laboratories opened at the day’s high and then formed a large red candle, indicating that higher levels attracted selling pressure.

Unlike many weak setups, the stock is still trading above its 50-day SMA near ₹154.54. That keeps the broader recovery structure intact for now, although the momentum has clearly softened.

The 14-day RSI has slipped to 57.40 after briefly moving close to overbought territory in recent sessions. This suggests that the rally is cooling and may enter a phase of consolidation rather than continuing immediately.

Key Technical Levels

The ₹150.00–140.00 zone may now act as the next area where the stock could attempt to stabilise if the weakness extends. On the higher side, the ₹178.00–190.00 band may continue to cap the upside unless the stock is able to recover from the current decline and regain momentum.

Source: TradingView

Risk to Watch

• The stock has shown a sharp rejection after approaching recent highs.
• A move below the 50-day SMA may weaken the broader recovery pattern.
• Low trading volumes can increase day-to-day volatility.
• Failure to reclaim the ₹178.00 area may keep the stock range-bound.

Summary

Arvee Laboratories has entered a pause after a strong rebound from recent lows. The latest session points to profit booking near the upper end of the range, but the stock still remains above its 50-day SMA. As long as that level holds, the broader structure may stay constructive, although momentum appears to be cooling in the near term.

FAQs

Why did Arvee Laboratories share price fall today?

The stock declined after failing to sustain near ₹178.00 and witnessing profit booking through the session.

What is the 50-day SMA for Arvee Laboratories?

The 50-day Simple Moving Average for Arvee Laboratories is currently near ₹154.54.

How much profit did Arvee Laboratories report in the December 2025 quarter?

Arvee Laboratories reported a standalone net profit of ₹182.69 lakh in the December 2025 quarter.